Abacus dx HGSA 2022 Showcase

Products are for Professional/Laboratory use only

Abacus dx creates value by connecting innovative global suppliers with Australasian customers. Find out more about our solutions for human genetics testing (inherited or acquired), the latest technologies, and innovations in molecular and cytogenetic diagnostics.

Abacus dx is proud to partner with high quality molecular diagnostics manufacturers including: Asuragen, Biocartis, Devyser, Invivoscribe and ZytoVision. 

Asuragen is a molecular diagnostic company changing the way patients are treated in genetics and oncology. For reproductive genetics, Asuragen’s AmplideX Trio can use one shared workflow to analyse CFTR, SMN1/2, and FMR1. This saves your lab tech time, simplifies training, and reduces consumables used.

Biocartis is an innovative molecular diagnostics company committed to revolutionise molecular testing with its unique Idylla platform. The Idylla platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from virtually any biological sample, in any setting, allowing fast and effective treatment selection.

Devyser are specialists when it comes to complex DNA testing within hereditary diseases and oncology with products used to guide targeted cancer therapies and enable rapid prenatal diagnostics. Included in their portfolio is the BRCA NGS kit for detection of BRCA1 and BRCA2 variants in germline and somatic samples, as well as their alpha and beta Thalassemia NGS one-tube solution.

Invivoscribe provides a comprehensive selection of PCR-based gene rearrangement, chromosome translocation, and gene mutation Research Use Only testing reagents and controls. They also provide CE-marked in vitro diagnostic products that are used to identify, classify and monitor leukemias, lymphomas and other lymphoproliferative diseases.

ZytoVision is an innovative company focused on the development and production of high quality, state-of-the-art diagnostic products of prognostic, predictive and therapeutic value, primarily for tumour diagnosis, based on the technique of in situ hybridization. They pride themselves on having the largest portfolio of up-to-date FISH and CISH probes covering solid tumour, haematology genetics and human pathogen viruses for research and diagnostics.